Vensana Capital
Venture capitalMinneapolis · Series A–Late Stage · 13 people tracked
Also known as VENSANA CAPITAL MANAGEMENT, LLC
Investment thesis
Vensana Capital invests in development-stage and commercial-stage companies across the medtech sector, including medical devices, diagnostics and data science, drug delivery, digital health, life science tools, and tech-enabled services. The firm emphasizes partnering with experienced, insightful, and bold management teams, aiming to invest where its capital and commitment amplify the success of its entrepreneurs. Its focus is on backing companies pursuing transformative innovation in healthcare technology.
Source: firm website, verified Aug 3, 2026.
Team · 13 people
from public directories
What they invest in
from 24 of 33 portfolio companiesHealthtech ×17Medical Devices ×16Biotech ×10AI & Machine Learning ×4Digital Health ×4Deep Tech ×3Data & Infrastructure ×1Hardware ×1
HQs:United States×20
Investments · 33 tracked
founders shown can be your intro pathCVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)Geoff Pardo(Director)Nadim Yared(Executive Officer, Director)Dean Bruhn-Ding(Executive Officer)John Brintnall(Executive Officer)Liz Galle(Executive Officer)
Board seatKirk Nielsen· per SEC Form D
BiotechGermantown, US
Mukul Jain(Executive Officer)Francine R. Kaufman(Executive Officer, Director)Rick Sullivan(Executive Officer)Kenneth L Horton(Executive Officer)Timothy T. Goodnow(Executive Officer, Director)Edward J. Fiorentino(Director)
Board seatPeter Justin Klein· per SEC Form D · $30M raise · filed Sep 2020
SpyGlass Pharma develops a sustained drug delivery system, the BIM-IOL System, that integrates long-acting glaucoma therapy into cataract surgery.
BiotechHealthtechMedical Devices
Vensana Innovation is a venture-backed startup studio ("innovation engine") that launches and builds medical technology companies, providing capital along with technical, clinical, commercial, and business development support at all stages from ideation to commercialization.
Deep TechHealthtechMedical Devices
Thomas Tu(CEO & Venture Partner)Brian(Founding Member)Ben(Co-founder)Phil Marchand
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)Jacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)
Board seatMaria BerkmanKirk NielsenKirk Nielsen· per SEC Form D
Artelon develops FLEXBAND, an elastic soft-tissue implant used to repair and augment tissue such as ankle ligaments, designed to maintain tension during motion and integrate into regenerating tissue over time.
BiotechHealthtechMedical DevicesMarietta, US
Greg Banker(Director)Aaron Smith(Executive Officer, Director)Mark Cohen(Director)Jeff Byrne(Executive Officer)Carter Meyer(Director)Kirk Nielsen(Director)
Board seatKirk Nielsen· per SEC Form D
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Aditya Rajagopal(Director)Paul Flook(Executive Officer, Director)James C. Blair(Director)Gregory J. Gosch(Executive Officer, Director)Axel Scherer(Director)Alexander G. Dickinson(Director)
Board seatJustin Klein· per SEC Form D
Denver, US
Board seatPeter Justin Klein· per SEC Form D · $106.3M raise · filed Dec 2024
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.
Deep TechHealthtechMedical DevicesRoseville, US
Corey Dishmon(Director)Todd Kerkow(Co-Founder, President and CEO)Mudit Jain(Co-Founder and Chairman of the Board)Robert Greenberg(Director)Kirk Nielsen(Director)Amrinder Singh(Director)
Board seatAmrinder SinghKirk Nielsen· per SEC Form D
Overnight automated insulin delivery
Wilmington, US
Peter N. Townsend(Director)Justin Klein(Director)John Sjolund(Chief Executive Officer of the Issuer)Jon Brilliant(Chief Financial Officer of the Issuer)Amrinder Singh(Director)
Board seatJustin KleinAmrinder Singh· per SEC Form D · $23.6M raise · filed Aug 2025
Monteris develops minimally invasive laser ablation technology for treating brain tumors and drug-resistant epilepsy.
Deep TechHealthtechMedical DevicesPlymouth, US
RICHARD EMMITT(Director)JAMES ERICKSON(Executive Officer)GREGORY BARRETT(Director)James Richardson(Director)DANIEL COLE(Director)MARTIN EMERSON(Executive Officer, Director)
Board seatKirk NielsenBill Hoffman· per SEC Form D · $13.7M raise · filed Sep 2022
BiotechAliso Viejo, US
Robert Rosenbluth(Director)Rhonda Robb(Executive Officer, Director)Brian J. Cox(Manager)
BoardDonald Milder(Director)Jonathan Root(Director)Paul Lubock(Director)
Board seatMike KramerKirk Nielsen· per SEC Form D
Baltimore, US
Board seatJustin Klein· per SEC Form D · $3.5M raise · filed May 2020
HealthtechBirmingham, US
Mike Kramer(Director)Kirk Nielsen(Director)Chase Wise(Director)James Robert Williamson, Jr.(Director)Robert E. Foster(Director)Tom Livingston(Executive Officer, Director)
Board seatMike KramerKirk Nielsen· per SEC Form D · $21.7M raise · filed May 2025
Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.
Medical DevicesRedwood City, US
Richard Mott(Director)Justin Klein(Director)Brent Ahrens(Director)Alex DiNello(Executive Officer, Director)Art Taylor(Director)Jason Lettman(Director)
Board seatJustin Klein· per SEC Form D
Tybrhealth develops the B3 GEL™ System, a protective gel applied during tendon and ligament repair surgery to reduce post-operative scar formation and preserve tissue mobility.
BiotechHealthtechMedical DevicesHouston, US
Tim Keane(Founder)inAlex Smith(Founder)inToby Hamilton(Director)Tom Dugan(Director)Jeffrey Tyber(Director)Timothy J. Keane, Jr.(Executive Officer, Director)
Board seatGreg Banker· per SEC Form D
BiotechSan Carlos, US
Matthew Sprinkel(Director)Justin Klein(Director)Surag Mantri(Executive Officer, Director)Amir Abolfathi(Director)Varun Gupta(Director)
Board seatJustin Klein· per SEC Form D
Edina, US
Thomas Tu(Executive Officer)William Hoffman(Executive Officer)Steven Schwen(Executive Officer)
Board seatMaria BerkmanKirk Nielsen· per SEC Form D · $25M raise · filed Aug 2025
Cleerly is an AI-enabled software platform that analyzes coronary artery disease through advanced imaging analysis, providing clinically actionable insights to support heart attack prevention and personalized patient care.
AI & Machine LearningHealthtechMedical Devices
Elucent Medical develops the EnVisio System, a surgical guidance platform that uses In-Body Spatial Intelligence and the SmartClip marker and SmartSensor to provide real-time 3D localization of tumors and target tissue.
HealthtechMedical Devices
Evident Vascular develops an intravascular ultrasound (IVUS) platform that uses AI for image interpretation and workflow improvements, aimed at peripheral vascular applications.
AI & Machine LearningHealthtechMedical Devices
HealthtechIrvine, US
Robert Rosenbluth(Executive Officer, Director)William H. Hoffman(Executive Officer, Director)Brian Cox(Director)Donald Milder(Director)Paul Lubock(Director)Kirk Nielsen(Director)
Metavention develops a treatment that targets the sympathetic nervous system to address high blood pressure and metabolic diseases using neuromodulation technology.
Medical Devices
Nyra Medical develops the CARLEN System, a transcatheter device for single-leaflet repair of functional mitral regurgitation that preserves native valve function.
BiotechDigital HealthMedical DevicesAtlanta, US
Dr. Murali Padala(Founder)Dr. Eric Sarin(Founder)Dr. Kirthana Suresh(Founder)Lori Chmura(CEO)Sai Muralidhar Padala(Executive Officer, Director)Amrinder Singh(Director)
HealthtechWayne, US
P. Sherrill Neff(Director)Neil Hattangadi(Director)Peter Schneider(Director)Mark Garcia(Director)Justin Klein(Director)Bruce J. Shook(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Fund performance · per public LP disclosures
as of Sep 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Vensana Capital I, L.P.LPs: San Diego City Employees' Retirement System, Richard King Mellon Foundation | 2018 | — | 16.9% | 1.53x | 0.57x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- What stage does Vensana Capital invest at?
- Vensana Capital invests at the Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Vensana Capital focus on?
- Vensana Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Vensana Capital located?
- Vensana Capital is headquartered in Minneapolis, US.
- Does Vensana Capital lead rounds?
- Vensana Capital typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamInvestor Forum Testimonial | Justin Klein, MD, JD, Vensana Capital
The MedTech Conference powered by AdvaMed · Justin Klein
Images
Co-investors · 16
Hatteras Venture Partners is a venture capital firm focused on early-stage life sciences and healthcare companies, backing therapeutics, diagnostics, and businesses aiming to transform healthcare delivery and innovation.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
Canaan is an early-stage venture capital firm backing founders with transformative ideas across technology and healthcare.
Northpond Ventures is a science- and technology-driven investment firm that backs breakthrough businesses aiming to have a significant impact on humanity.
Domain Associates (DomainVC) is a life sciences venture capital firm that served as investment advisors to the first VC fund dedicated to biotech and as investment manager of nine subsequent biotech VC funds.
Longitude Capital is a venture growth investment firm focused on biotechnology, medical technology, and health solutions companies aiming to improve clinical outcomes, patient quality of life, and cost of care. It invests in both private and public companies across multiple structures.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Founders Fund is a venture capital firm that invests in companies building transformative technologies across defense, space, data analytics, and other frontier sectors.
Highland Capital Partners is a venture capital firm with a 39-year history focused on backing entrepreneurs, reporting 200 exits, over 50 IPOs, 40 unicorns, and $7B in assets under management.
Presight Capital is the international venture fund of entrepreneur Christian Angermayer, operating as a registered investment adviser that can invest across public and private markets with checks from $500K to $100M+ throughout a company's entire lifecycle from seed to post-IPO. The fund is backed by prominent hedge fund managers and billionaire angels rather than traditional institutional investors, and focuses heavily on controversial frontier science like psychedelics, brain-computer interfaces, and life extension alongside transformative infrastructure bets in undercapitalized global markets.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Flagship Pioneering is a firm that creates and builds companies to pioneer breakthroughs in science and technology for people and the planet, active for over 25 years.
▶4 more co-investors
Firms observed investing alongside Vensana Capital, from public investor directories. Shared companies are the overlap with Vensana Capital's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.